心脑血管病发病率走高 专家详解动粥疾病治疗误区

2015-05-13 唐贵江 中国新闻网

在第五届“5·18血管健康日”来临之际,广州医科大学附属第二医院神经内科副主任高聪教授12日接受采访时称,随着中国人口老龄化趋势的发展,心脑血管病发病率日趋走高,动粥疾病等高危人群更应实施干预,保护血管健康。  对于普通公众来说,动脉粥状硬化(动粥疾病)这个词可能显得生僻,但其实普通公众所知的冠心病、心肌梗死、缺血性脑卒中等心脑血管疾病都属于动粥疾病范畴;据了解,我国动粥疾病已成为超过癌症、是死亡

在第五届“5·18血管健康日”来临之际,广州医科大学附属第二医院神经内科副主任高聪教授12日接受采访时称,随着中国人口老龄化趋势的发展,心脑血管病发病率日趋走高,动粥疾病等高危人群更应实施干预,保护血管健康。
  
对于普通公众来说,动脉粥状硬化(动粥疾病)这个词可能显得生僻,但其实普通公众所知的冠心病、心肌梗死、缺血性脑卒中等心脑血管疾病都属于动粥疾病范畴;据了解,我国动粥疾病已成为超过癌症、是死亡率最高的疾病。
  
据介绍,正常的动脉内壁光滑、坚实而富有弹性,而发生粥样硬化后的动脉,由于血脂沉积于动脉内膜,内膜纤维化,形成粥样斑块,血管壁也随之增厚、僵硬、钙化,这个过程即俗称的“粥样”硬化。
  
动脉粥样硬化会逐渐阻塞血管,使血流变慢,引发冠心病和脑卒中等心脑血管疾病;更危险的是,不稳定的斑块破裂或脱落,会在短时间内堵塞血管,导致急性心肌梗死或脑中风,危及生命。
  
高聪教授介绍,随着中国老龄化趋势的发展,在她的接诊过程中,越来越多的患者出现动粥疾病,包括:冠心病、发生过心梗、缺血性脑卒中、有糖尿病的以及高血压合并冠心病等的这类人群,是动粥疾病的高危和极高危人群,也是心脑血管疾病极高危和高危人群。
  
以往动粥疾病往往被视为老人病,高聪教授表示,这是一个误区,根据她目前正在研究的课题,动粥疾病正有年轻化的趋势,她接触到的40岁以下的病例也有不少,因此年轻人并不能忽视自己的心血管健康。
  
健康的生活方式和适当的药物治疗,被高聪视为是治疗动粥疾病的两大要素。高聪介绍,愉快的心情、充足的睡眠、均衡的饮食和适当的锻炼,这是人们想保持健康的四大基石;对于动粥疾病患者,除了这些科学的生活方式以外,还必须接受适当的药物治疗。
  
高聪教授建议,人们应积极检查胆固醇。20岁以上成年人,至少每5年测量1次空腹血脂。而40岁以上的人群,建议每年都进行检测;心脑血管疾病及其他高危人群,则应每3-6个月测量1次血脂。
  
对于高危患者来说,高聪建议应坚持他汀治疗。大量循证医学研究证实,他汀类药物是动脉粥样硬化性心血管疾病管理的基石,能够减少主要血管事件,例如死亡、心肌梗死和中风的疗效已超越所有其他类调脂药物。
  
有不少动粥疾病的高危病人在治疗过程中,服药一段时间后胆固醇就开始下降到正常值范围内,然后往往拒绝继续服药,高聪称,这也是一大误区,他汀药物的治疗不仅仅可以降低胆固醇的数量,还能起到稳定斑块的作用,只有医生指导下坚持长期服药,才能更有效地保证健康,防止复发。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1644434, encodeId=dd32164443405, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Mon Nov 09 02:36:00 CST 2015, time=2015-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018781, encodeId=abed2018e8132, content=<a href='/topic/show?id=d79e51e1967' target=_blank style='color:#2F92EE;'>#心脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51719, encryptionId=d79e51e1967, topicName=心脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Oct 16 15:36:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823237, encodeId=e299182323e58, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Jan 12 23:36:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982744, encodeId=e5e01982e44e3, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Thu Jul 23 21:36:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308753, encodeId=723b1308e5331, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri May 15 04:36:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23310, encodeId=606523310e7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=182.149.192.**, createdTime=Wed May 13 20:09:00 CST 2015, time=2015-05-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1644434, encodeId=dd32164443405, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Mon Nov 09 02:36:00 CST 2015, time=2015-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018781, encodeId=abed2018e8132, content=<a href='/topic/show?id=d79e51e1967' target=_blank style='color:#2F92EE;'>#心脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51719, encryptionId=d79e51e1967, topicName=心脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Oct 16 15:36:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823237, encodeId=e299182323e58, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Jan 12 23:36:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982744, encodeId=e5e01982e44e3, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Thu Jul 23 21:36:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308753, encodeId=723b1308e5331, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri May 15 04:36:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23310, encodeId=606523310e7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=182.149.192.**, createdTime=Wed May 13 20:09:00 CST 2015, time=2015-05-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1644434, encodeId=dd32164443405, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Mon Nov 09 02:36:00 CST 2015, time=2015-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018781, encodeId=abed2018e8132, content=<a href='/topic/show?id=d79e51e1967' target=_blank style='color:#2F92EE;'>#心脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51719, encryptionId=d79e51e1967, topicName=心脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Oct 16 15:36:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823237, encodeId=e299182323e58, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Jan 12 23:36:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982744, encodeId=e5e01982e44e3, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Thu Jul 23 21:36:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308753, encodeId=723b1308e5331, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri May 15 04:36:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23310, encodeId=606523310e7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=182.149.192.**, createdTime=Wed May 13 20:09:00 CST 2015, time=2015-05-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1644434, encodeId=dd32164443405, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Mon Nov 09 02:36:00 CST 2015, time=2015-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018781, encodeId=abed2018e8132, content=<a href='/topic/show?id=d79e51e1967' target=_blank style='color:#2F92EE;'>#心脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51719, encryptionId=d79e51e1967, topicName=心脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Oct 16 15:36:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823237, encodeId=e299182323e58, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Jan 12 23:36:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982744, encodeId=e5e01982e44e3, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Thu Jul 23 21:36:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308753, encodeId=723b1308e5331, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri May 15 04:36:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23310, encodeId=606523310e7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=182.149.192.**, createdTime=Wed May 13 20:09:00 CST 2015, time=2015-05-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1644434, encodeId=dd32164443405, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Mon Nov 09 02:36:00 CST 2015, time=2015-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018781, encodeId=abed2018e8132, content=<a href='/topic/show?id=d79e51e1967' target=_blank style='color:#2F92EE;'>#心脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51719, encryptionId=d79e51e1967, topicName=心脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Oct 16 15:36:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823237, encodeId=e299182323e58, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Jan 12 23:36:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982744, encodeId=e5e01982e44e3, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Thu Jul 23 21:36:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308753, encodeId=723b1308e5331, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri May 15 04:36:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23310, encodeId=606523310e7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=182.149.192.**, createdTime=Wed May 13 20:09:00 CST 2015, time=2015-05-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1644434, encodeId=dd32164443405, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Mon Nov 09 02:36:00 CST 2015, time=2015-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018781, encodeId=abed2018e8132, content=<a href='/topic/show?id=d79e51e1967' target=_blank style='color:#2F92EE;'>#心脑血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51719, encryptionId=d79e51e1967, topicName=心脑血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Oct 16 15:36:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823237, encodeId=e299182323e58, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Jan 12 23:36:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982744, encodeId=e5e01982e44e3, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Thu Jul 23 21:36:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308753, encodeId=723b1308e5331, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri May 15 04:36:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23310, encodeId=606523310e7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=182.149.192.**, createdTime=Wed May 13 20:09:00 CST 2015, time=2015-05-13, status=1, ipAttribution=)]
    2015-05-13 182.149.192.**

    看看

    0

相关资讯

中国心血管中成药市场分析结果

中国心血管中成药市场:越往基层中成药使用比例越高,主要处方医生以西医为主 本文摘自IMS Pharma Insights咨询总监史思民先生在广州IMS Health中药市场论坛上的演讲《中国心血管领域中成药市场深度解读》部分章节。该文章不代表本刊观点。 中国心脑血管疾病患者人群十分庞大,未来十年心脑血管疾病中成药市场年复合增长率将达到14.5%。有效控制高血压,高血脂和糖尿病对于

心脑血管疾病预防抗栓专家协作组在京成立

  人民网北京4月8日电(周雷刚)中国预防医学会心脑血管疾病预防抗栓专家协作组近日在京成立。   目前,人们生活水平在提高的同时,运动时间却相对减少,卒中、冠心病、高血压、糖尿病等各种慢性病正吞噬着人们的健康。《2011年中国慢病报告》指出,中国2.36亿的高血压患者和9681万的糖尿病人群使心脑血管风险人群数量大大增加。而且,中国已步入老龄化的人口模式期,60岁以上人口已占人口数量的13

中国心脑血管疾病患者已超2.3亿人

  中国心脑血管疾病患者已超过2.3亿人,每年的死亡人数近300万。这是卫生部医政司综合处处长樊静11日在北京透露的。   她在此间举办的“承载使命,迎接拐点”中国血管健康工程启动仪式上称:“由于疾病谱的改变以及不良生活方式导致的心脑血管疾病仍然是危害着公民主要的疾病负担。”   卫生部心血管疾病介入诊疗技术管理专家工作组组长霍勇称,心脑血管疾病的死亡率过去10年居高不下,与其他疾病相比,死亡